Source comparison
BPC-157 TB-500 Stack Protocol: Research Application Comparison
Tendon/Ligament Repair 250–500mcg daily 2.5–5mg daily or every other day 6–8 weeks Increased collagen density, improved fiber alignment, 20–35% greater tensile strength vs control Muscle Injury Recovery 300–500mcg daily 2–5mg daily 4–6 weeks Reduced fibrosis,
This comparison does not assign a generated winner or score.
- Tendon/Ligament Repair
- 250–500mcg daily
- 2.5–5mg daily or every other day
- 6–8 weeks
- Increased collagen density, improved fiber alignment, 20–35% greater tensile strength vs control
- Muscle Injury Recovery
- 300–500mcg daily
- 2–5mg daily
- 4–6 weeks
- Reduced fibrosis, faster myofibril regeneration, decreased inflammatory infiltrate
- Gastric/Intestinal Models
- 200–400mcg daily
- 2–3mg every other day
- Accelerated mucosal healing, reduced ulcer area, restored epithelial barrier function
- Vascular/Cardiac Research
- 5mg daily (higher dose for systemic effect)
- Enhanced angiogenesis, reduced infarct size, improved capillary density in ischemic tissue
- The dosing ranges reflect published preclinical studies and should be adjusted for the specific animal model and tissue type. Higher TB-500 doses (5mg+) are used in cardiac and vascular models where systemic distribution is critical, while tendon and ligament protocols use moderate doses with localized BPC-157 injection to maximize site-specific angiogenesis.